Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Midostaurin

EU orphan designation number: EU/3/04/214   
Active ingredient: Midostaurin
Indication: Treatment of acute myeloid leukaemia
Sponsor: Novartis Europharm Limited
Frimley Business Park, Camberley GU16 7SR, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/08/2004 Orphan Designation EMEA/OD/028/04 (2004)3094 of 29/07/2004
29/08/2014 Change of address of sponsor